- Companies
- Vi Labs
Vi Labs Funding, Investors & Competitors
Vi Labs has raised $147M across 3 funding rounds, most recently a $111M undisclosed-stage round in June 2024.
Last Vi Labs funding round
$111M
Undisclosed stage · Jun 2024
Cumulative funding Vi Labs raised
$147M
across 3 funding rounds
Key investors in Vi Labs
Square Peg Capital
Cerca Partners
Triventures
Wellborn Ventures
General Atlantic
World Trade Ventures
Savano Capital Partners
Alpha Partners
About Vi Labs
Vi Labs is a Boston-based enterprise AI platform for healthcare payers and providers. The system processes claims, EHRs, and member data to predict high-risk patients, optimize care pathways, and reduce costs by 15-20 percent. Deployed at Blue Cross Blue Shield affiliates and hospital networks, it employs natural language processing for utilization management and personalized interventions.
Founded
2016
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Vi Labs Funding History
Vi Labs has raised a total of $147M across 3 funding rounds.
Vi Labs' first fundraising round was a $16M seed round in March 2016. The most recent completed round was a $111M undisclosed-stage round in June 2024.
Vi Labs funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Jun 2024 | Undisclosed stage | General Atlantic (lead); Alpha Partners; Savano Capital Partners | $111M | Vi Labs has raised a total of $157.6M in funding, with its latest reported round being a $20M Convertible Note on April 26, 2024, and General Atlantic participating in a prior Growth Equity round. Vi Labs has made one acquisition, purchasing Motus Consumer Insights on December 12, 2022. |
| Jan 2018 | Series A | New Era Ventures; Wellborn Ventures; FGI Capital Partners; Triventures; Square Peg Capital; Joy Ventures; Cerca Partners | $20M | Vi Technologies, previously known as LifeBeam, raised $20 million in a funding round around early 2018 from investors including Joy Ventures, Square Peg Capital (also referred to as Squarepeg Capital), New Era Ventures, Cerca Partners (Cerca Capital), Triventures, Wellborn Ventures, FGI Capital Partners, and angel investors, bringing total funding to nearly $40 million. The company, matching Vi Labs, develops an AI fitness wearable called Vi, a voice-based assistant launched after a 2016 Kickstarter, originally focused on biosensing technology. Proceeds were intended to expand the AI fitness business across connected audio devices and brand partnerships. Later developments include a $20M convertible note in April 2024 and total funding of $151-157.6M, with an acquisition of Motus Consumer Insights in 2022. |
| Mar 2016 | Seed | Square Peg Capital (lead); Wellborn Ventures; Atomics 14 Ventures; Triventures; World Trade Ventures; Cerca Partners | $16M | Vi Labs, founded in 2011 by Omri Joffe, develops an AI platform for digital health and fitness, providing personalized audio coaching, machine learning insights from connected devices, and an SDK for fitness brands. The platform processes data to enhance engagement, retention, and health outcomes for users and trainers. Square Peg Capital partnered with Vi Labs in 2016 in a pre-seed round, with additional investors including Atomics 14 Ventures, Cerca Partners, Triventures, Wellborn Ventures, and World Trade Ventures. The company has raised a total of approximately $157.6M to $41.09M across rounds, with later funding including a $20M convertible note in April 2024 and a September 2021 valuation of $225M. Vi Labs serves over 30 million members daily and acquired Motus Consumer Insights in December 2022. |
Who has invested in Vi Labs?
12 investors have backed Vi Labs across its funding rounds, including Square Peg Capital, Cerca Partners, Triventures, Wellborn Ventures, General Atlantic and World Trade Ventures.
Lead investors include General Atlantic and Square Peg Capital.
Vi Labs Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 2 | Participant | Mar 2016 | ||
| 2 | Participant | Mar 2016 | ||
| 2 | Lead | Mar 2016 | ||
| 2 | Participant | Mar 2016 | ||
| 1 | Participant | Jun 2024 | ||
| 1 | Participant | Jan 2018 | ||
| 1 | Participant | Mar 2016 | ||
| 1 | Participant | Jan 2018 | ||
| 1 | Lead | Jun 2024 | ||
| 1 | Participant | Mar 2016 | ||
This data is available for Pro users. Sign up to see all 12 Vi Labs investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialVi Labs Competitors
Vi Labs competitors include listed companies like IQVIA, ICON plc and Privia Health, and private ones like Innovaccer, NantHealth and Unite Us.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $16B | $3.4B | $44B | 3.4x | ||
| Publicly listed | $8.3B | $816M | $13B | 1.9x | ||
| Private | $250M | - | $3.5B | 13.8x | ||
| Publicly listed | $2.1B | $44M | $2.6B | 0.9x | ||
| Private | $58M | - | $2B | - | ||
| Private | - | - | $1.6B | - |
Vi Labs Public Comps
Vi Labs is still privately-owned, but its public comps include IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, GE HealthCare, Revvity, Solventum, Tempus AI, ICON plc and Pro Medicus.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $16B | $3.4B | 3.6x | 3.4x | 17.2x | 14.8x | |||
| $3.2B | $965M | 11.1x | 10.2x | 36.9x | 22.4x | |||
| $4.3B | $1.5B | 9.5x | 8.9x | 27.1x | 24.9x | |||
| $7.9B | $3.2B | 6.1x | 5.7x | 15.2x | 14.6x | |||
| $21B | $3.7B | 1.8x | 1.8x | 10.1x | 10.0x | |||
| $2.9B | $735M | 6.5x | 6.6x | 25.4x | 21.0x | |||
| $8.3B | $2.5B | 2.4x | 2.4x | 7.8x | 8.9x | |||
| $1.3B | ($131M) | 12.0x | 10.1x | (116.0x) | 346.0x | |||
This data is available for Pro users. Sign up to see all Vi Labs competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Vi Labs
| When was Vi Labs founded? | Vi Labs was founded in 2016. |
| Where is Vi Labs headquartered? | Vi Labs is headquartered in New York City, NY, United States. |
| Is Vi Labs publicly listed? | No, Vi Labs is a private, VC-backed company. |
| How much funding has Vi Labs raised? | Vi Labs has raised $147M across 3 funding rounds. |
| What was Vi Labs' last funding round? | Vi Labs' last funding round was a $111M undisclosed-stage round in June 2024, led by General Atlantic. |
| Who are Vi Labs' investors? | Vi Labs' investors include Wellborn Ventures, Triventures, Square Peg Capital, Cerca Partners, Alpha Partners, New Era Ventures, Atomics 14 Ventures, FGI Capital Partners, General Atlantic, World Trade Ventures and 2 others. |
| Which companies are comparable to Vi Labs? | Companies comparable to Vi Labs include IQVIA, ICON plc, Innovaccer, Privia Health, NantHealth and Unite Us. |
See companies similar to Vi Labs
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




